Home » Celgene Seeks European Cancer Acquisition
Celgene Seeks European Cancer Acquisition
Celgene, the U.S. group best known for reviving thalidomide as a treatment for cancer, is keen to buy a European company to increase its global reach, Chief Executive John Jackson said on Thursday. "We are always looking at opportunities to buy companies and ideally we would love to buy a European company that has a cancer pipeline plus marketing infrastructure in Europe," he told Reuters during a visit to London.
()a href="http://today.reuters.com/news/newsArticle.aspx?type=healthNews&storyID=2005-05-19T125929Z_01_L19442329_RTRIDST_0_HEALTH-CELGENE-EUROPE-DC.XML" target="_blank">Reuters
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May